Smith & Nephew (LON:SN) Stock Passes Above Two Hundred Day Moving Average - What's Next?

Key Points

• Smith & Nephew shares have crossed above their 200-day moving average, reaching a trading price of GBX 1,435 ($19.42), with a significant volume of 2.31 million shares traded.
• Analysts have shown confidence in Smith & Nephew, with price targets raised by firms like JPMorgan and Deutsche Bank, and a consensus rating of "Hold".
• Insider activity includes multiple purchases, amounting to a total of 4,811 shares acquired by corporate insiders over the past 90 days.

Smith & Nephew plc (LON:SN - Get Free Report)'s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 1,136.08 ($15.51) and traded as high as GBX 1,435 ($19.59). Smith & Nephew shares last traded at GBX 1,435 ($19.59), with a volume of 2,313,437 shares changing hands.

Analysts Set New Price Targets

SN has been the subject of a number of analyst reports. Berenberg Bank boosted their price target on Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the stock a "hold" rating in a research report on Thursday, August 7th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the company a "hold" rating in a research note on Wednesday, August 6th. Finally, JPMorgan Chase & Co. increased their target price on shares of Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the company an "overweight" rating in a research report on Wednesday, August 6th. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of GBX 1,379.33.

Smith & Nephew Stock Down 1.4%

The company has a debt-to-equity ratio of 70.22, a current ratio of 2.51 and a quick ratio of 0.84. The stock has a market capitalization of £15.18 billion, a P/E ratio of 49.87, a PEG ratio of 0.46 and a beta of 0.62. The stock's fifty day moving average is GBX 1,282.60 and its two-hundred day moving average is GBX 1,144.55.

Insider Buying and Selling at Smith & Nephew

In related news, insider Katarzyna Mazur Hofsaess bought 541 shares of Smith & Nephew stock in a transaction dated Friday, August 22nd. The stock was acquired at an average cost of GBX 1,385 per share, with a total value of £7,492.85. Also, insider Angie Risley purchased 373 shares of the firm's stock in a transaction that occurred on Friday, August 22nd. The stock was bought at an average price of GBX 1,382 per share, with a total value of £5,154.86. Over the last quarter, insiders purchased 4,811 shares of company stock worth $12,947,701. 0.19% of the stock is owned by insiders.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.